GHK-Cu Copper Peptide: What It Actually Is and What It's Evidenced For

GHK-Cu is glycyl-L-histidyl-L-lysine bound to a copper ion: a small tripeptide your own body already makes, found in blood plasma, saliva and urine. Skincare and hair-care brands isolate a synthetic, purity-controlled version of the same molecule and put it into serums. The evidence behind it splits into two clearly different tiers. On facial skin, there is a modest but real body of human research. For hair growth specifically, the case leans on cell-culture and animal work, plus a couple of results a brand can describe but a reader cannot independently check, rather than a published controlled trial in people. Both things are true of the same ingredient at once, which is why "copper peptide" turns up constantly in skincare marketing and gets a far more cautious mention in hair-loss content that takes the evidence seriously.

• One specific molecule, several names. GHK-Cu is also sold as "copper tripeptide-1". A related but shorter tripeptide, AHK-Cu, is the one usually cited when a brand talks about hair rather than skin.
• The clearest human evidence sits on facial skin, with modest firmness and fine-line improvements reported after about twelve weeks in small trials.
• The hair-growth case rests mainly on one 2007 organ-culture study and a set of unpublished 1990s trials, not a controlled human trial you can look up.
• A copper peptide serum works best alongside minoxidil, not instead of it, since minoxidil is the only ingredient in Quintéa's range with an approved regrowth indication.

What GHK-Cu Actually Is

GHK-Cu occurs naturally in the body: it circulates in blood plasma and has also been detected in saliva and urine (source: Copper peptide GHK-Cu, Wikipedia). The glycine end of the tripeptide is what actually grips the copper ion, and that grip is loose enough that the molecule can carry copper into a cell and release it again rather than locking it away permanently. Plasma levels are not static over a lifetime: research summarising the ingredient's biology puts GHK at around 200 ng/mL in a twenty-year-old and closer to 80 ng/mL by age sixty, a decline researchers have used to argue for a link between falling GHK and some of the visible signs of ageing skin (source: Pickart & Margolina, International Journal of Molecular Sciences, 2018).

The version in a bottle is not extracted from anyone. It is manufactured in a lab so that every batch has the same purity and concentration, which is the only practical way to formulate a product around it. Worth separating early: "copper peptide" as a marketing term is loose enough to cover more than one molecule. GHK-Cu is the one with most of the skin research behind it. AHK-Cu is shorter, related, and the one that shows up specifically in hair-growth claims, including in the Copper Peptide Serum you'll see mentioned further down.

How It's Thought to Work, and Where That Evidence Comes From

In fibroblast cell culture, GHK-Cu prompts cells to make more collagen and other matrix proteins at strikingly low concentrations, in the picomolar-to-nanomolar range, and it prompts the release of other signalling proteins, including basic fibroblast growth factor (bFGF) and nerve growth factor (NGF). Separately, in animal studies on rats, rabbits and pigs, wounds treated with GHK-Cu tended to heal faster than untreated wounds (source: Pickart & Margolina, International Journal of Molecular Sciences, 2018). That combination, a plausible cell-level mechanism plus supportive animal data, is genuinely why researchers kept studying this molecule for decades.

It is also exactly where the honest reading has to slow down. A dish of fibroblasts and a rat's shaved back are not the same system as intact human skin, let alone a human scalp, where blood supply, immune activity and the hair follicle's own growth cycle all complicate the picture. A laboratory or animal result is a starting point for further research, not proof that the same thing happens when you apply a serum to your own skin.

What the Evidence Actually Shows for Skin

The strongest human data sits here, on facial skin, and it is still modest. One frequently cited trial followed 71 women with photoaged skin for twelve weeks and reported reduced wrinkling and improved skin density with a GHK-Cu-containing cream (source: Pickart & Margolina, International Journal of Molecular Sciences, 2018). That is a real, human, controlled result, and it is also a single study of a type that is easy to overstate: a twelve-week window, a formulation-specific outcome, and, as with a fair amount of ingredient research, funding and authorship connections to the companies that develop and sell the ingredient.

Independent commentary from within the skincare industry describes the wider body of copper-peptide research the same way: mostly small in scale, and mostly run in cell culture rather than in large, independent human trials (source: Dermalogica, "Copper Peptides (GHK-Cu)"). None of that makes the facial-skin findings meaningless. It does mean "modest improvement in a small trial" is a more accurate summary than any claim of guaranteed or dramatic results, and it is worth remembering that this is the strongest part of the copper-peptide evidence base, not the weakest.

What About Hair? The Evidence Is Much Thinner

Once the conversation moves from skin to hair, the evidence tier changes, and the ingredient usually being discussed changes too. The hair story is generally attached to AHK-Cu rather than GHK-Cu. According to the Copper Peptide Serum's own product description, a 2007 laboratory study applied AHK-Cu to isolated human hair follicles kept alive in organ culture, and separately to cultured dermal papilla cells, and reported more follicle elongation, more cell proliferation and more VEGF release. That is a genuine, specific result, and it is worth being precise about what it is: a result inside a culture dish, on tissue removed from the body, not a measurement of hair regrowth on a person's head.

The same product description also references company-run trials of a copper-peptide scalp solution for pattern hair loss in the 1990s. Those trials, per the seller's own account, never led to an approved product, and the full results were never published anywhere a reader can look them up and check the methodology or the numbers. Both of these claims come from the product's own description rather than from an independent, checkable source, which is worth knowing as you weigh them: they are the manufacturer's account of the ingredient's history, not peer-reviewed literature.

Put together, there is a plausible mechanism and one genuine in-vitro result, and there is no controlled human trial demonstrating that a copper peptide regrows hair. That puts copper peptides in a different evidence tier from minoxidil, the one ingredient in this range with an approved regrowth indication and trial data in actual people behind it. For the full breakdown of what is and is not evidenced for hair specifically, including how AHK-Cu's laboratory result compares with other ingredients making similar claims, see the dedicated look at copper peptides and hair-growth evidence.

Where a Copper Peptide Serum Fits in a Routine

Given the evidence above, the honest way to position a copper peptide serum is as care for the condition of scalp and facial skin, not as something acting on the hair-growth cycle itself. That distinction matters in practice: the scalp is skin, and treating hair loss is often hard on it. Topical minoxidil is typically carried in alcohol with propylene glycol, and adding a dermaroller opens the skin's surface deliberately. A serum aimed at skin condition is a reasonable thing to reach for if months of treatment have left the scalp feeling irritated, used alongside a treatment rather than as a substitute for one.

For anyone deciding between starting this serum and starting an evidence-backed treatment, the more consequential choice is Minoxidil Topical Solution USP, 5%, the ingredient with an approved regrowth indication and controlled human trial data behind it. Sequencing also matters if you use both: copper complexes like this one are destabilised by strong acids and by direct vitamin C, so those are best kept to a morning routine, with the copper peptide serum applied at night. If minoxidil goes on the same scalp the same evening, apply the serum first and give it time to absorb fully before the minoxidil, rather than layering the two at once.

Readers comparing minoxidil-free options more broadly may also find it useful to see how another cosmetic ingredient in the range, Redensyl, is evidenced (a parallel look at what Redensyl actually is and what the evidence shows), or to step back and see how several peptides compare side by side (a field guide to peptides used for hair growth). If your interest in a copper peptide is specifically about beard rather than scalp use, that has its own separate considerations, covered in what copper peptides can and can't do for beard growth.

Quick Answers

Is every "copper peptide" the same as GHK-Cu?

No. GHK-Cu, also sold under the name copper tripeptide-1, is the specific molecule behind most of the skin research described above. "Copper peptide" as a marketing phrase is used more loosely, and in hair-care products it often refers instead to AHK-Cu, a related but shorter tripeptide with a much smaller, mostly cell-culture evidence base of its own.

Does a higher percentage work better?

Not in any way the current evidence supports. The cell-culture work behind GHK-Cu found effects at picomolar-to-nanomolar concentrations, figures too small to translate neatly into a simple "more on the label equals a stronger effect" rule, and no published trial has established a dose-response relationship for GHK-Cu or AHK-Cu on human skin or scalp. A product's listed percentage reflects how the formula was built, not a proven potency curve, so it is not a reliable way to compare products against each other.

None of this makes GHK-Cu a pointless ingredient to have in a routine, and none of it makes it a treatment for hair loss. It is a well-studied molecule with a genuine, if modest, evidence base on facial skin and a mechanism that is interesting enough to keep researchers looking at hair too, without yet having the controlled human data to back a hair-growth claim. Used with that distinction in mind, alongside rather than in place of an ingredient like minoxidil that does have that data, a copper peptide serum is a reasonable, honestly described addition to a scalp and skin routine.